SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 72 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $365,000 | -40.1% | 20,981 | -24.6% | 0.00% | – |
Q4 2021 | $609,000 | +19.4% | 27,826 | +4.2% | 0.00% | – |
Q3 2021 | $510,000 | -5.0% | 26,700 | -14.7% | 0.00% | – |
Q2 2021 | $537,000 | -24.2% | 31,289 | -1.2% | 0.00% | – |
Q1 2021 | $708,000 | +51.9% | 31,669 | +51.2% | 0.00% | – |
Q4 2020 | $466,000 | +79.9% | 20,946 | +19.2% | 0.00% | – |
Q3 2020 | $259,000 | -19.3% | 17,566 | -19.0% | 0.00% | – |
Q2 2020 | $321,000 | +66.3% | 21,686 | +23.1% | 0.00% | – |
Q1 2020 | $193,000 | +11.6% | 17,621 | -10.7% | 0.00% | – |
Q4 2019 | $173,000 | +16.9% | 19,727 | -0.5% | 0.00% | – |
Q3 2019 | $148,000 | -13.5% | 19,826 | +8.3% | 0.00% | – |
Q2 2019 | $171,000 | +147.8% | 18,314 | +39.2% | 0.00% | – |
Q1 2019 | $69,000 | -82.8% | 13,152 | -61.7% | 0.00% | – |
Q3 2017 | $401,000 | -21.5% | 34,310 | -6.2% | 0.00% | -100.0% |
Q2 2017 | $511,000 | +64.3% | 36,565 | +61.4% | 0.00% | – |
Q1 2017 | $311,000 | +87.3% | 22,654 | -2.0% | 0.00% | – |
Q4 2016 | $166,000 | -53.6% | 23,127 | -2.0% | 0.00% | -100.0% |
Q3 2016 | $358,000 | +56.3% | 23,591 | +1.3% | 0.00% | – |
Q2 2016 | $229,000 | – | 23,293 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,025,000 | $21,648,000 | 10.42% |
Foresite Capital Management IV, LLC | 875,000 | $18,480,000 | 9.59% |
Kynam Capital Management, LP | 3,205,986 | $67,710,424 | 8.74% |
Frazier Life Sciences Management, L.P. | 3,708,838 | $78,330,659 | 5.67% |
ACUTA CAPITAL PARTNERS, LLC | 330,000 | $6,969,600 | 5.13% |
Paradigm Biocapital Advisors LP | 2,274,512 | $48,037,693 | 4.55% |
Eversept Partners, LP | 2,209,057 | $46,655,284 | 3.25% |
DAFNA Capital Management LLC | 447,073 | $9,442,182 | 2.83% |
COMMODORE CAPITAL LP | 853,884 | $18,034,030 | 2.75% |
Avidity Partners Management LP | 3,865,300 | $81,635,136 | 2.71% |